WPI 3739 (Hydromorphone Hydrochloride Extended-Release 12 mg)
Pill with imprint WPI 3739 is Yellow, Round and has been identified as Hydromorphone hydrochloride extended-release 12 mg. It is supplied by Watson Laboratories, Inc..
Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 12 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3739
More about hydromorphone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 371 Reviews – Add your own review/rating
- Drug class: narcotic analgesics
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone Extended-Release Tablets
- Hydromorphone Tablets
- ... +4 more
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.